-
The most recent ada/easd algorithm for management of type 2 diabetes (DM2) indicates basal insulin as an appropriate next step if glycemic goals are not attained with metformin and lifestyle interventions.
-
Sleep-deprived individuals appear less healthy, tired, and less attractive to untrained observers than when they are rested.
-
The FDA has approved a second dipeptidyl peptidase-4 (DPP-4) inhibitor and metformin combination. This follows the approval of sitagliptin/metformin in 2007.
-
The surface ECG shows the net result of electrical forces that are operative. This concept is important to remember when potential "competing conditions" are operative.
-
Acetaminophen is able to induce a significant increase in BP in ambulatory subjects with CAD.
-
Most adrenal masses found inadvertently as part of an investigation for another illness are benign. The work-up for an adrenal incidentaloma is presented.
-
Immunochemical fecal occult blood testing (i-FOBT) is becoming increasingly popular as a screening tool for colorectal cancer (CRC).
-
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
-
In a prospective, randomized, double-blind, placebo-controlled trial of women taking SRI's, sildenafil treatment resulted in a reduction of sexual side effects.
